Drug

Emodepside clinical trials

studies test it: 10
open now: 2
in phase 3: 3
first study started: 2015

How each study uses emodepside is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the emodepside studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Emodepside: 5
emodepside (BAY 44-4400): 4

Development codes

BAY 44-4400: 1

Studies by the year they started

10 studies that test it; most in 2015 (2)

Studies that test emodepside, by start year
Year	Studies
2015	2
2017	1
2021	2
2022	1
2024	1
2025	1
2026	2

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 5
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Onchocerciasis: 1
Strongyloidiasis: 1
Hookworm Infections: 1
Filariasis: 1
Trichuriasis: 1

Who runs them

Industry 0 · Other 10

Drugs for Neglected Diseases (3) · Swiss Tropical & Public Health Institute (3) · Jennifer Keiser (3) · University of Giessen (1)

Often tested with

Tested in the same studies.

Vincristine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test emodepside, phase 3 first.

Jun 2027Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth InfectionsPhase 3 · Swiss Tropical & Public Health Institute
Jan 2027Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris IncognitaPhase 2 · Jennifer Keiser

Studies

Open first, then newest update. How each study uses emodepside is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Codes

What other systems call emodepside · ClinicalTrials.gg INT004490

MeSH (NLM) C468987emodepsideConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) YZ647Y5GC9EMODEPSIDEConfirmed FDA, NLM, Wikidata
RxNorm 354606Confirmed FDA, Wikidata
Wikidata Q1339032emodepsideConfirmed FDA, NLM, Wikidata
NCI Thesaurus C90726EmodepsideOne source FDA
DrugBank DB11403One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C468987	emodepside	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	YZ647Y5GC9	EMODEPSIDE	Confirmed FDA, NLM, Wikidata
RxNorm	354606	—	Confirmed FDA, Wikidata
Wikidata	Q1339032	emodepside	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C90726	Emodepside	One source FDA
DrugBank	DB11403	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.